195 related articles for article (PubMed ID: 33257451)
1. A Matched Case-Case-Control Study of the Impact of Clinical Outcomes and Risk Factors of Patients with IMP-Type Carbapenemase-Producing Carbapenem-Resistant
Saito S; Hayakawa K; Tsuzuki S; Ishikane M; Nagashima M; Mezaki K; Sugiki Y; Tajima T; Matsunaga N; Ide S; Kinoshita N; Kusama Y; Fujitomo Y; Nakamoto T; Toda Y; Kaku M; Kodama EN; Ohmagari N
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33257451
[TBL] [Abstract][Full Text] [Related]
2. Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae.
Hayakawa K; Nakano R; Hase R; Shimatani M; Kato H; Hasumi J; Doi A; Sekiya N; Nei T; Okinaka K; Kasahara K; Kurai H; Nagashima M; Miyoshi-Akiyama T; Kakuta R; Yano H; Ohmagari N
J Antimicrob Chemother; 2020 Mar; 75(3):697-708. PubMed ID: 31789374
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.
Wang Q; Zhang Y; Yao X; Xian H; Liu Y; Li H; Chen H; Wang X; Wang R; Zhao C; Cao B; Wang H
Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1679-89. PubMed ID: 27401905
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of carbapenem-resistant
Yan WJ; Jing N; Wang SM; Xu JH; Yuan YH; Zhang Q; Li AL; Chen LH; Zhang JF; Ma B; Ma Q; Li Y
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33587030
[No Abstract] [Full Text] [Related]
5. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M
Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053
[TBL] [Abstract][Full Text] [Related]
6. The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.
Asai N; Sakanashi D; Suematsu H; Kato H; Hagihara M; Nishiyama N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2018 Jul; 24(7):505-509. PubMed ID: 29548627
[TBL] [Abstract][Full Text] [Related]
7. Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.
Chiotos K; Tamma PD; Flett KB; Naumann M; Karandikar MV; Bilker WB; Zaoutis T; Han JH
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971864
[TBL] [Abstract][Full Text] [Related]
8. Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.
Tamma PD; Goodman KE; Harris AD; Tekle T; Roberts A; Taiwo A; Simner PJ
Clin Infect Dis; 2017 Feb; 64(3):257-264. PubMed ID: 28013264
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China.
Liu J; Zhang L; Pan J; Huang M; Li Y; Zhang H; Wang R; Zhao M; Li B; Liu L; Gong Y; Bian J; Li X; Tang Y; Lei M; Chen D
J Infect Dis; 2020 Mar; 221(Suppl 2):S156-S163. PubMed ID: 32176797
[TBL] [Abstract][Full Text] [Related]
10. Molecular and epidemiological characterization of IMP-type metallo-β-lactamase-producing Enterobacter cloacae in a Large tertiary care hospital in Japan.
Hayakawa K; Miyoshi-Akiyama T; Kirikae T; Nagamatsu M; Shimada K; Mezaki K; Sugiki Y; Kuroda E; Kubota S; Takeshita N; Kutsuna S; Tojo M; Ohmagari N
Antimicrob Agents Chemother; 2014 Jun; 58(6):3441-50. PubMed ID: 24709261
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.
Marimuthu K; Venkatachalam I; Khong WX; Koh TH; Cherng BPZ; Van La M; De PP; Krishnan PU; Tan TY; Choon RFK; Pada SK; Lam CW; Ooi ST; Deepak RN; Smitasin N; Tan EL; Lee JJ; Kurup A; Young B; Sim NTW; Thoon KC; Fisher D; Ling ML; Peng BAS; Teo YY; Hsu LY; Lin RTP; Ong RT; Teo J; Ng OT;
Clin Infect Dis; 2017 May; 64(suppl_2):S68-S75. PubMed ID: 28475792
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2127-2135. PubMed ID: 28639165
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.
Pfaller MA; Huband MD; Mendes RE; Flamm RK; Castanheira M
Int J Antimicrob Agents; 2018 Aug; 52(2):144-150. PubMed ID: 29510189
[TBL] [Abstract][Full Text] [Related]
14. Role of Double-Carbapenem Regimen in the Treatment of Infections due to Carbapenemase Producing Carbapenem-Resistant
Cancelli F; Oliva A; De Angelis M; Mascellino MT; Mastroianni CM; Vullo V
Biomed Res Int; 2018; 2018():2785696. PubMed ID: 30581848
[TBL] [Abstract][Full Text] [Related]
15. Molecular and Epidemiological Characteristics of Carbapenemase-Producing Klebsiella pneumoniae Clinical Isolates in Japan.
Yonekawa S; Mizuno T; Nakano R; Nakano A; Suzuki Y; Asada T; Ishii A; Kakuta N; Tsubaki K; Mizuno S; Ogawa M; Yano H; Kasahara K; Mikasa K
mSphere; 2020 Oct; 5(5):. PubMed ID: 33087515
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of multidrug-resistant Enterobacteriaceae in Sri Lanka: First evidence of bla
Kumudunie WGM; Wijesooriya LI; Namalie KD; Sunil-Chandra NP; Wijayasinghe YS
J Infect Public Health; 2020 Sep; 13(9):1330-1335. PubMed ID: 32439355
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes and Treatment Strategies in Patients With Non-Carbapenemase-producing Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacterales Infections.
Debnath A; Pillinger KE; Martin AJ; Dobrzynski D; Cameron A; Shulder S
Ann Pharmacother; 2023 Jul; 57(7):803-812. PubMed ID: 36268974
[TBL] [Abstract][Full Text] [Related]
18. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
Cunha CB; Kassakian SZ; Chan R; Tenover FC; Ziakas P; Chapin KC; Mermel LA
Am J Infect Control; 2016 Feb; 44(2):126-30. PubMed ID: 26631643
[TBL] [Abstract][Full Text] [Related]
19. Performance evaluation of three automated identification systems in detecting carbapenem-resistant Enterobacteriaceae.
He Q; Chen W; Huang L; Lin Q; Zhang J; Liu R; Li B
Ann Clin Microbiol Antimicrob; 2016 Jun; 15(1):40. PubMed ID: 27328762
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological Characteristics of Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae Colonization.
Jeong IS; Song JY
Asian Nurs Res (Korean Soc Nurs Sci); 2022 Aug; 16(3):134-139. PubMed ID: 35605957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
